Table 2.
Characteristics of studies about combined D-dimer and other biomarkers included in the analysis
No | Author | Year | Sample | Disease | Biomarker | AUC | Sen | Spe | Youden index | No. Case | No. Control | References |
---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Yang | 2020 | Plasma | TAD | D-dimer + hs-CRP + ANGPTL8 | 0.9270 | 0.7950 | 0.9850 | 0.7800 | 78 | 72 | [23] |
2 | Yang | 2020 | Plasma | TAD | D-dimer + ANGPTL8 | 0.9090 | 0.8330 | 0.8940 | 0.7270 | 78 | 72 | [23] |
3 | Xiao | 2016 | Serum | AAD | Lumican + D-dimer | 0.9620 | 0.8833 | 0.9500 | 0.8330 | 60 | 60 | [28] |
4 | Giachino | 2013 | Plasma | AAD | log2MMP8 + D-dimer | 0.8900 | 1.0000 | 0.1310 | 0.1310 | 52 | 74 | [37] |
5 | He | 2019 | Plasma | AAD | SAA + D-dimer | 0.9000 | 0.8480 | 0.9380 | 0.7860 | 63 | 87 | [39] |
6 | Ma | 2021 | Serum | AAD | CP + D-dimer | 0.7070 | 0.6360 | 0.9410 | 0.5770 | 102 | 85 | [21] |
AUC, area under the curve of receiver operator characteristics. Sen, sensitivity. Spe, specificity. AAD, acute aortic dissection